Citations for
1SCA17, TBP
Deactivation of TBP contributes to SCA17 pathogenesis.
Hsu TC, Wang CK, Yang CY, Lee LC, Hsieh-Li HM, Ro LS, Chen CM, Lee-Chen GJ, Su MT.
Hum Mol Genet. Dec 20;23(25):6878-93. doi: 10.1093/hmg/ddu410. Epub 2014 Aug 7 2014
2NFYA, SCA17, TBP
Role of the CCAAT-binding protein NFY in SCA17 pathogenesis.
Lee LC, Chen CM, Wang HC, Hsieh HH, Chiu IS, Su MT, Hsieh-Li HM, Wu CH, Lee GC, Lee-Chen GJ, Lin JY.
PLoS One 7(4):e35302. doi: 10.1371/journal.pone.0035302. Epub 2012 Apr 17. 2012
3SCA17, TBP
Neuroprotective effects of granulocyte-colony stimulating factor in a novel transgenic mouse model of SCA17.
Chang YC, Lin CY, Hsu CM, Lin HC, Chen YH, Lee-Chen GJ, Su MT, Ro LS, Chen CM, Hsieh-Li HM.
J Neurochem 118(2):288-303. doi: 10.1111/j.1471-4159.2011.07304.x. Epub 2011 Jun 2. 2011
4SCA17, SCA2, SCA3
Relative contribution of SCA2, SCA3 and SCA17 in Korean patients with parkinsonism and ataxia.
Yun JY, Lee WW, Kim HJ, Kim JS, Kim JM, Kim HJ, Kim SY, Kim JY, Park SS, Kim YK, Kim SE, Jeon BS.
Parkinsonism Relat Disord 17(5):338-42. doi: 10.1016/j.parkreldis.2011.01.015. Epub 2011 Feb 19. 2011
5SCA17, TBP
SCA17 repeat expansion: mildly expanded CAG/CAA repeat alleles in neurological disorders and the functional implications.
Chen CM, Lee LC, Soong BW, Fung HC, Hsu WC, Lin PY, Huang HJ, Chen FL, Lin CY, Lee-Chen GJ, Wu YR.
Clin Chim Acta 411(5-6):375-80. doi: 10.1016/j.cca.2009.12.002. Epub 2009 Dec 11. 2010
6SCA17, TBP
Spinocerebellar ataxia type 17 mutation as a causative and susceptibility gene in parkinsonism.
Kim JY, Kim SY, Kim JM, Kim YK, Yoon KY, Kim JY, Lee BC, Kim JS, Paek SH, Park SS, Kim SE, Jeon BS.
Neurology 72(16):1385-9. 2009
7SCA17
Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17.
Gao R, Matsuura T, Coolbaugh M, ZŸhlke C, Nakamura K, Rasmussen A, Siciliano MJ, Ashizawa T, Lin X.
Eur J Hum Genet 16(2):215-22. Epub 2007 Nov 28. 2008
8SCA17, TBP
Repeat expansion in spinocerebellar ataxia type 17 alleles of the TATA-box binding protein gene: an evolutionary approach.
Tomiuk J, Bachmann L, Bauer C, Rolfs A, Schols L, Roos C, Zischler H, Schuler MM, Bruntner S, Riess O, Bauer P.
Eur J Hum Genet 15(1):81-7. Epub 2006 Oct 11. 2007
9SCA17, TBP
Anticipation and intergenerational repeat instability in spinocerebellar ataxia type 17.
Rasmussen A, De Biase I, Fragoso-Benítez M, Macías-Flores MA, Yescas P, Ochoa A, Ashizawa T, Alonso ME, Bidichandani SI.
Ann Neurol 61(6):607-10. 2007
10SCA17, TBP
Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17).
Hübner J, Sprenger A, Klein C, Hagenah J, Rambold H, Zühlke C, Kömpf D, Rolfs A, Kimmig H, Helmchen C.
Neurology 69(11):1160-8. 2007
11SCA17
Spinocerebellar ataxia type 17 (SCA17): oculomotor phenotype and clinical characterization of 15 Italian patients.
Mariotti C, Alpini D, Fancellu R, Soliveri P, Grisoli M, Ravaglia S, Lovati C, Fetoni V, Giaccone G, Castucci A, Taroni F, Gellera C, Di Donato S.
J Neurol 254(11):1538-46. Epub 2007 Oct 15.PMID: 17934876 2007
12SCA17
Phenotypic homogeneity of the Huntington disease-like presentation in a SCA17 family.
Schneider SA, van de Warrenburg BP, Hughes TD, Davis M, Sweeney M, Wood N, Quinn NP, Bhatia KP.
Neurology 67(9):1701-3. 2006
13SCA1, ATXN1, SCA2, ATXN2, MJD, ATXN3, SCA6, CACNA1A, SCA7, ATXN7, SCA17, TBP, DRPLA, ATN1, SBMA, AR
Transcriptional alterations and chromatin remodeling in polyglutamine diseases.
Helmlinger D, Tora L, Devys D.
Trends Genet 22(10):562-70. Epub 2006 Sep 5. 2006
14SCA17
Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17).
Lasek K, Lencer R, Gaser C, Hagenah J, Walter U, Wolters A, Kock N, Steinlechner S, Nagel M, ZŸhlke C, Nitschke MF, Brockmann K, Klein C, Rolfs A, Binkofski F.
Brain 129(Pt 9):2341-52. Epub 2006 Jun 7. 2006
15FXN, FRDA, FRAXA, FMR1, FRAXE, ATXN1, SCA1, ATXN2, SCA2, ATXN3, MJD, ATXN7, SCA7, SCA6, CACNA1A, SCA17, TBP, DRPLA, ATN1, AR, SBMA, DM1, DMPK, DM2, CNBP, SCA10, ATXN10, SCA12, PPP2R2B, SCA8, ATXN8OS
Diseases of unstable repeat expansion: mechanisms and common principles.
Gatchel JR, Zoghbi HY.
Nat Rev Genet 6(10):743-55. Review. 2005
16SCA8, SCA17
Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease.
Wu YR, Lin HY, Chen CM, Gwinn-Hardy K, Ro LS, Wang YC, Li SH, Hwang JC, Fang K, Hsieh-Li HM, Li ML, Tung LC, Su MT, Lu KT, Lee-Chen GJ.
Clin Genet 65(3):209-14. 2004
17SCA17
Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype.
Bauer P, Laccone F, Rolfs A, Wullner U, Bosch S, Peters H, Liebscher S, Scheible M, Epplen JT, Weber BH, Holinski-Feder E, Weirich-Schwaiger H, Morris-Rosendahl DJ, Andrich J, Riess O.
J Med Genet 41(3):230-2. No abstract available. 2004
18SCA17, TBP
Small de novo duplication in the repeat region of the TATA-box-binding protein gene manifest with a phenotype similar to variant Creutzfeldt-Jakob disease.
Shatunov A, Fridman EA, Pagan FI, Leib J, Singleton A, Hallett M, Goldfarb LG.
Clin Genet 66(6):496-501. 2004
19SCA17, TBP
SCA17 caused by homozygous repeat expansion in TBP due to partial isodisomy 6.
Zuhlke CH, Spranger M, Spranger S, Voigt R, Lanz M, Gehlken U, Hinrichs F, Schwinger E.
Eur J Hum Genet 11(8):629-32. 2003
20SCA17
Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17).
Rolfs A, Koeppen AH, Bauer I, Bauer P, Buhlmann S, Topka H, Schols L, Riess O.
Ann Neurol 54(3):367-75. 2003
21SCA17, TBP
SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein.
Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, Nagashima T, Ikeda S, Tsuji S, Kanazawa I.
Hum Mol Genet 10(14):1441-8. 2001
22SCA17, TBP
CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia.
Fujigasaki H, Martin JJ, De Deyn PP, Camuzat A, Deffond D, Stevanin G, Dermaut B, Van Broeckhoven C, Durr A, Brice A.
Brain 124(Pt 10):1939-47. 2001